CalciMedica, Inc. Common Stock
CALCCalciMedica, Inc. is a biotechnology company focused on developing therapies that target calcium signaling pathways involved in inflammatory and immune responses. Their innovative treatments aim to address diseases such as acute respiratory distress syndrome (ARDS), inflammatory bowel disease, and other immune-related conditions. The company leverages cutting-edge research to develop novel solutions to improve patient outcomes.
Company News
Here is how Alcon (ALC) and CalciMedica Inc. (CALC) have performed compared to their sector so far this year.
The Dow Jones index closed lower by around 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insid...
As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, ...
The Dow Jones closed higher by around 35 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider tran...
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. FaZe Holdings Inc. (NASDAQ: FAZE) gained 46.9% to $0.2247 after falling over 4% on Friday. Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares climbed 23.5% to $0.1472 after ...
